Detalles de la búsqueda
1.
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC.
Ann Oncol
; 28(6): 1339-1345, 2017 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28327953
2.
Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL.
Ann Oncol
; 27(2): 286-94, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26578735
3.
Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate therapy in patients with metastatic castration-resistant prostate cancer? An analysis of abiraterone acetate phase III trials.
Ann Oncol
; 27(4): 699-705, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26609008
4.
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC.
Ann Oncol
; 29(11): 2269, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29390043
5.
A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer.
Invest New Drugs
; 31(1): 115-25, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22415798
6.
Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior docetaxel and abiraterone acetate.
Ann Oncol
; 28(3): 668, 2017 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28426121
7.
Safety and efficacy of the combination of erlotinib and sirolimus for the treatment of metastatic renal cell carcinoma after failure of sunitinib or sorafenib.
Br J Cancer
; 103(6): 796-801, 2010 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-20823888
8.
Functionalized gold nanorods for thermal ablation treatment of bladder cancer.
J Biomed Nanotechnol
; 10(7): 1267-76, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24804547
9.
Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer.
Prostate Cancer Prostatic Dis
; 17(1): 34-9, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24080993
10.
Tivozanib: practical implications for renal cell carcinoma and other solid tumors.
Drugs Today (Barc)
; 49(5): 303-15, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23724410
11.
Axitinib, a new therapeutic option in renal cell carcinoma.
Drugs Today (Barc)
; 48(10): 633-44, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23110259
Resultados
1 -
11
de 11
1
Próxima >
>>